Breakthroughs in Oral and Maxillofacial Surgery

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dentistry, Oral Surgery and Oral Medicine".

Deadline for manuscript submissions: closed (25 March 2023) | Viewed by 32662

Special Issue Editors


E-Mail Website
Guest Editor
Department of Health Sciences, School of Dentistry, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy
Interests: dentistry; oral surgery; implant dentistry; MRONJ; teledentistry; telemedicine; regenerative dentistry; oral medicine
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Post-Graduate School of Oral Surgery, Department of Health Sciences, University of Catanzaro “Magna Graecia”, 88100 Catanzaro, Italy
Interests: bone augmentation procedures; dental implantology; maxillofacial surgery; oral pathology; oral surgery; platelet-rich fibrin
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
School of Dentistry, Department of Health Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy
Interests: dental implantology; oral surgery; osteonecrosis of the jaws; platelet concentrates; platelet-rich fibrin; third molar surgery

Special Issue Information

Dear Colleagues,

Over the last few years, oral and maxillofacial surgery (OMFS) has seen significant improvements in the medical and dental fields. This specialty includes the diagnosis and the surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and aesthetic aspects of the hard and soft tissues of the oral and maxillofacial region.

In recent years, clinicians and researchers have made several significant changes in every aspect of OMFS from diagnosis to treatment. In particular, the synergy between oral surgery, maxillofacial surgery and oral pathology plays a role of primary importance in the management of patients with oro-maxillary problems. Recently, the attention of the research has been focused on new therapeutic and diagnostic approaches in the management of diseases of the oral cavity, on innovative surgical techniques for the rehabilitation of atrophic jaws, on the use of new procedures of hard and soft tissues regeneration and on the virtual surgical planning. For this reason, the therapeutic–diagnostic approach requires an important effort by researchers and health professionals.

For this Special Issue on "Breakthroughs Oral and Maxillofacial Surgery" we invite you to submit proposals in every field of research on innovation in oral and maxillofacial surgery.

Topics may include (but are not limited to):

- Implant-prosthetic rehabilitation of the jaws;

- Management of oral diseases;

- New approaches and technologies in oral-maxillofacial surgery;

- Regenerative techniques of hard and soft tissues;

- Medication-related osteonecrosis of the jaws;

- New diagnostic and therapeutic tools in the management of oral potentially malignant disorders;

- Oral mesenchymal stem cells.

Dr. Alessandro Antonelli
Prof. Dr. Amerigo Giudice
Dr. Francesco Bennardo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Implant-prosthetic rehabilitation
  • Oral diseases
  • Oral and Maxillofacial Surgery
  • Medication-related osteonecrosis of the jaws
  • Oral mesenchymal stem cells
  • Virtual surgical planning
  • Oral cancer
  • Oral pontentially malignant disorders
  • Regenerative dentistry

Published Papers (15 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review, Other

4 pages, 184 KiB  
Editorial
Breakthroughs in Oral and Maxillofacial Surgery
by Alessandro Antonelli, Francesco Bennardo and Amerigo Giudice
J. Clin. Med. 2024, 13(3), 685; https://doi.org/10.3390/jcm13030685 - 24 Jan 2024
Cited by 1 | Viewed by 634
Abstract
In the field of oral and maxillofacial surgery, continuous advances have ushered in a new era of innovation, profoundly influencing this branch of medicine [...] Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)

Research

Jump to: Editorial, Review, Other

11 pages, 4415 KiB  
Article
Comparison between the Flapless Surgical Approach and a Novel Single Incision Access in Terms of Recovery Time and Comfort after Extraction of Impacted Inferior Third Molars: A Randomised, Blinded, Split-Mouth Controlled Clinical Trial
by Alberto Materni, Claudio Pasquale, Antonio Signore, Stefano Benedicenti and Andrea Amaroli
J. Clin. Med. 2023, 12(5), 1995; https://doi.org/10.3390/jcm12051995 - 02 Mar 2023
Cited by 1 | Viewed by 2637
Abstract
The recent attention to quality of life and oral health care procedures reflects a renewed ‘patient-based’ approach to dealing with non-life-threatening conditions. In the current study, we proposed a novel surgical approach to the extraction of impacted inferior third molars (iMs3) through a [...] Read more.
The recent attention to quality of life and oral health care procedures reflects a renewed ‘patient-based’ approach to dealing with non-life-threatening conditions. In the current study, we proposed a novel surgical approach to the extraction of impacted inferior third molars (iMs3) through a randomised, blinded, split-mouth controlled clinical trial following the CONSORT guidelines. The novel surgical procedure, hereinafter referred to as single incision access (SIA), will be compared with our previously described flapless surgical approach (FSA). The predictor variable was the novel SIA approach, involving access through a single incision without removal of soft tissue, on the impacted iMs3. The primary endpoint was the acceleration of the iMs3 extraction healing time. The secondary endpoints were the incidences of pain and oedema as well as gum health (pocket probing depth and attached gingiva). The study was carried out on 84 teeth of 42 patients with both iMs3 impacted. The cohort was composed of 42% Caucasian males and 58% Caucasian females, aged 23.8 ± 7.9 (17–49) years. We observed faster recovery/wound-healing on the SIA side (33.6 ± 4.3 days) than at the FSA side (42.1 ± 5.4 days; p < 0.05). The FSA approach confirmed the evidence previously detected concerning early post-surgery improvement in terms of attached gingiva and reduced oedema and pain, with respect to the traditional envelope flap. The novel SIA approach follows the early positive post-surgery FSA results. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

16 pages, 267 KiB  
Article
Analysis of the Validity of Perioperative Antibiotic Prophylaxis in Maxillofacial Surgery
by Iwona Niedzielska, Marcin Kotowski, Anna Mertas, Michał Bąk, Szczepan Barnaś and Damian Niedzielski
J. Clin. Med. 2022, 11(19), 5812; https://doi.org/10.3390/jcm11195812 - 30 Sep 2022
Viewed by 1012
Abstract
Perioperative antibiotic prophylaxis is the standard in surgical departments. The type of operation, the duration of the procedure, the degree of microbiological purity of the operating field and the current clinical condition of the patient determine its administration. The aim of this study [...] Read more.
Perioperative antibiotic prophylaxis is the standard in surgical departments. The type of operation, the duration of the procedure, the degree of microbiological purity of the operating field and the current clinical condition of the patient determine its administration. The aim of this study was to validate the antibiotic prophylaxis used in a Maxillofacial Surgery Department for a group of trauma and non-trauma patients. To that end, an observational prospective cohort study was carried out. The study was conducted on a group of 83 patients of the Department of Cranio-Maxillo-Facial Surgery who were divided into a group of trauma patients (n = 43) and one of non-trauma patients (n = 40). In both groups, the classic microbiological tests were carried out, and the results were analyzed in relation to: the study group, age, sex, duration of surgery, type of surgical access. Most bacterial strains were isolated at the initial stage of the operation. Gram (+) cocci were isolated more often in the trauma group and Gram (−) rods in the non-trauma group. Significantly more often, strains of fungi were noted in the initial stage of the procedure in the trauma group. We conclude that the use of perioperative antibiotic prophylaxis in the Maxillofacial Surgery Departments is justified. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
11 pages, 1145 KiB  
Article
Ozone Infiltration for Osteonecrosis of the Jaw Therapy: A Case Series
by Olga Di Fede, Carmine Del Gaizo, Vera Panzarella, Gaetano La Mantia, Pietro Tozzo, Anna Di Grigoli, Antonio Lo Casto, Rodolfo Mauceri and Giuseppina Campisi
J. Clin. Med. 2022, 11(18), 5307; https://doi.org/10.3390/jcm11185307 - 09 Sep 2022
Cited by 10 | Viewed by 1970
Abstract
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction, mainly due to bone-modifying agents (BMA), and it is a potentially painful and debilitating condition. To date, the literature has reported a 90% rate of successful outcomes for MRONJ patients undergoing surgical [...] Read more.
Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction, mainly due to bone-modifying agents (BMA), and it is a potentially painful and debilitating condition. To date, the literature has reported a 90% rate of successful outcomes for MRONJ patients undergoing surgical treatment. Particularly for patients with advanced disease stages who are unsuitable for surgery, prolonged medical treatment is required, with a consequent risk of the overuse of antibiotics and antibiotic resistance. The aim of this study is to evaluate the efficiency and safety of ozone, via oral mucosal infiltrations, in seven cancer patients with MRONJ, who are not eligible for surgery. The protocol (OZOPROMAF) consists of intratissue injections of an oxygen ozone (O2O3) mixture, which is applied until formation of a sequestrum and clinical healing. Follow-up was scheduled to confirm the healing of MRONJ and radiological evaluations by CBCT were planned. In order to assess the level of pain, a questionnaire including the Numeric Rating Scale for Pain (NRS Pain) was administered on the first visit, one day after treatment, and one week after treatment. After an application of OZOPROMAF, all patients reported discomfort for some hours, probably due to soft tissue pressure around the infiltration site. Thereafter, the discomfort subsided within 6–8 h. Complete mucosal healing of MRONJ occurred within a number of cycles ranging from 7 to 16. Complete resolution with an improvement in bone condition was observed in all patients. The MRONJ lesions of all patients healed after 18–24 months. The authors of this study contend that these preliminary results suggest the efficiency and safety of the O2O3 mixture. However, further research is required to confirm the efficacy of the O2O3 mixtures in MRONJ treatment, at least for patients who are unsuitable for surgery. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

8 pages, 1643 KiB  
Article
The Role of Full-Thickness Skin Grafts in Patient’s Rehabilitation after Maxillectomy and Midface Defects
by Iwona Niedzielska, Łukasz Obszyński, Michał Bąk and Damian Niedzielski
J. Clin. Med. 2022, 11(13), 3608; https://doi.org/10.3390/jcm11133608 - 22 Jun 2022
Viewed by 1392
Abstract
(1) Background: Nowadays, microvascular grafts are the gold standard in the reconstruction of midface defects after maxillectomy, however, not all patients may qualify for this type of surgery. The purpose of present study is to evaluate the benefits of alternative reconstruction methods such [...] Read more.
(1) Background: Nowadays, microvascular grafts are the gold standard in the reconstruction of midface defects after maxillectomy, however, not all patients may qualify for this type of surgery. The purpose of present study is to evaluate the benefits of alternative reconstruction methods such as full-thickness skin grafts for these conditions. (2) Methods: The research group consisted of 37 patients who underwent maxillectomy due to cancer of the mid-face and had full-thickness skin graft reconstruction. The study covered the period from 2011 to 2020. (3) Results: Based on the clinical examination and the subjective assessment of patients, a positive effect of the use of free skin grafts on their convalescence and rehabilitation was found. In particular, they contributed to the reduction in postoperative pain and pain associated with prosthetic stages (VAS Scale). (4) Conclusion: Full-thickness skin grafts in combination with individual prosthetic restorations are a good alternative to rehabilitation in patients who do not qualify for microsurgical treatment. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

9 pages, 1861 KiB  
Article
Mandibular Molar Uprighting Using Skeletal Anchorage: A Novel Approach
by Luca Sbricoli, Sara Ricci, Andrea Cattozzo, Riccardo Favero, Eriberto Bressan and Stefano Sivolella
J. Clin. Med. 2022, 11(13), 3565; https://doi.org/10.3390/jcm11133565 - 21 Jun 2022
Cited by 6 | Viewed by 2434
Abstract
Background: The management of eruption anomalies affecting second molars, although quite uncommon, may represent a real challenge for the clinician. The aim of this study is to present a novel technique that combines the surgical and orthodontic approach in order to obtain the [...] Read more.
Background: The management of eruption anomalies affecting second molars, although quite uncommon, may represent a real challenge for the clinician. The aim of this study is to present a novel technique that combines the surgical and orthodontic approach in order to obtain the retrieval of impacted second molars through a complex distalizing movement and skeletal anchorage. Methods: Nineteen consecutive patients with impacted second molars were treated according to this technique, which involved extraction of the third molar followed by the placement of a distally positioned screw, and the subsequent use of a coil spring to connect the screw to an eyelet directly bonded on the second molar. In selected cases, it proved to be necessary to reposition the second molar through traditional orthodontics. All of the parameters were recorded: the time required for completing the treatment, the initial angle between the second molar and the adjacent tooth, and treatment related-complications. Results: Twenty impacted second molars were correctly repositioned. The mean initial angle of the second molar was 55.7° (SD 22.6°, min 13.3°, max 104.8°). The mean treatment time was 10 months. There were no major complications. Conclusions: Given that periodontal tissues were minimally affected, the temporary anchorage device was fully controlled, and there was no unwanted movement of adjacent teeth, the presented technique not only proved effective but also minimally invasive. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

16 pages, 1745 KiB  
Article
Oral and Maxillofacial Infections—A Bacterial and Clinical Cross-Section
by Bartłomiej Kamiński, Katarzyna Błochowiak, Konrad Kołomański, Maciej Sikora, Sławomir Karwan and Dariusz Chlubek
J. Clin. Med. 2022, 11(10), 2731; https://doi.org/10.3390/jcm11102731 - 12 May 2022
Cited by 8 | Viewed by 2518
Abstract
The treatment of oral and maxillofacial infections is based on a recognized algorithm that may require modification under the influence of various local and systemic factors. The aim of this study was to present a comprehensive and microbiological profile of oral and maxillofacial [...] Read more.
The treatment of oral and maxillofacial infections is based on a recognized algorithm that may require modification under the influence of various local and systemic factors. The aim of this study was to present a comprehensive and microbiological profile of oral and maxillofacial infections, and explore possible correlations between the course of an infection and selected systemic factors based on the medical records of 329 patients affected by the disease. We identified most common clinical, demographic, bacterial, and laboratory parameters specific for these infections. There were statistically significant differences in Erythrocyte Sedimentation Rate, number of accompanying diseases, otalgia, dyspnea, and speech difficulties occurrence and neck space involvement between diabetic and non-diabetic patients. The duration of hospitalization and accompanying diseases correlated positively with the patient age and white blood cell count, and C-reactive protein value negatively correlated with age. The primary cause of infections, age, and comorbid diseases can modify the infection course and increase the risk of developing serious complications. It confirms the need for effective and targeted bacterial treatment in the early stages of infections. Age and general diseases are the most important systemic factors determining the infection symptoms and laboratory parameters assessing the severity of the inflammatory process. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

9 pages, 1608 KiB  
Article
The Accuracy of Jaws Repositioning in Bimaxillary Orthognathic Surgery in Patients with Cleft Lip and Palate Compared to Non-Syndromic Skeletal Class III Patients
by Benedetta Bollato, Martina Barone, Antonio Gracco, Ugo Baciliero, Giorgia Crivellin, Giovanni Bruno and Alberto De Stefani
J. Clin. Med. 2022, 11(9), 2675; https://doi.org/10.3390/jcm11092675 - 09 May 2022
Cited by 2 | Viewed by 1633
Abstract
Background: The present study aims to compare the accuracy of jaw repositioning in bimaxillary orthognathic surgery using digital surgical planning in cleft lip and palate patients and in non-syndromic skeletal class III patients in order to investigate if orthognathic surgery achieves different [...] Read more.
Background: The present study aims to compare the accuracy of jaw repositioning in bimaxillary orthognathic surgery using digital surgical planning in cleft lip and palate patients and in non-syndromic skeletal class III patients in order to investigate if orthognathic surgery achieves different results in the first group of patients. Method: This study included 32 class III adult patients divided into 2 groups: cleft lip and palate (A, n = 16) and non-cleft (B, n = 16). For each patient, a 2D pre-surgical visual treatment objective was performed by the surgeon to predict hard tissue changes, and the surgical outcome was compared with that planned by using cephalometric measurement (ANB, SNA, SNB, Ar-Go-Me, S-Ar-Go). The statistical analysis showed equivalence between obtained and planned results for each measurement both in group A and in group B, but the difference between the planned and the obtained result was smaller in group B regarding ANB angle. Conclusions: Digital surgical planning ensures better predictability of the surgical results and higher accuracy of surgery in complex patients, such as those with cleft lip and palate. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

11 pages, 3042 KiB  
Article
Effects of Type 2 Diabetes Mellitus on Osteoclast Differentiation, Activity, and Cortical Bone Formation in POSTmenopausal MRONJ Patients
by Sung-Min Park and Jae-Hoon Lee
J. Clin. Med. 2022, 11(9), 2377; https://doi.org/10.3390/jcm11092377 - 23 Apr 2022
Cited by 2 | Viewed by 1862
Abstract
Osteoporosis is a common metabolic bone disease in patients with diabetes, which can develop simultaneously with type 2 diabetes (T2D) in postmenopausal women. Bisphosphonate (BP) is administered to patients with both conditions and may cause medication-related osteonecrosis of the jaw (MRONJ). It affects [...] Read more.
Osteoporosis is a common metabolic bone disease in patients with diabetes, which can develop simultaneously with type 2 diabetes (T2D) in postmenopausal women. Bisphosphonate (BP) is administered to patients with both conditions and may cause medication-related osteonecrosis of the jaw (MRONJ). It affects the differentiation and function of osteoclasts as well as the thickness of the cortical bone through bone mineralization. Therefore, this study aimed to investigate the effects of T2D on osteoclast differentiation and activity as well as cortical bone formation in postmenopausal patients with MRONJ. Tissue samples were collected from 10 patients diagnosed with T2D and stage III MRONJ in the experimental group and from 10 patients without T2D in the control group. A histological examination was conducted, and the expression of dendritic cell-specific transmembrane protein (DC-STAMP) and tartrate-resistant acid phosphatase (TRAP) was assessed. Cortical bone formation was analyzed using CBCT images. The number of TRAP-positive osteoclasts and DC-STAMP-positive mononuclear cells was significantly less in the experimental group (p < 0.05). Furthermore, the thickness and ratio of cortical bone were significantly greater in the experimental group (p < 0.05). In conclusion, T2D decreased the differentiation and function of osteoclasts and increased cortical bone formation in postmenopausal patients with MRONJ. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

17 pages, 3684 KiB  
Article
Identification of Potentially Pathogenic Variants Associated with Recurrence in Medication-Related Osteonecrosis of the Jaw (MRONJ) Patients Using Whole-Exome Sequencing
by Songmi Kim, Seyoung Mun, Wonseok Shin, Kyudong Han and Moon-Young Kim
J. Clin. Med. 2022, 11(8), 2145; https://doi.org/10.3390/jcm11082145 - 12 Apr 2022
Cited by 3 | Viewed by 2074
Abstract
Background: Bisphosphonates are antiresorptive and antiangiogenic drugs that prevent and treat bone loss and mineralization in women with postmenopausal osteoporosis and cancer patients. Medication-related osteonecrosis of the jaw (MRONJ) is commonly caused by tooth extraction and dental trauma. Although genetic and pathological studies [...] Read more.
Background: Bisphosphonates are antiresorptive and antiangiogenic drugs that prevent and treat bone loss and mineralization in women with postmenopausal osteoporosis and cancer patients. Medication-related osteonecrosis of the jaw (MRONJ) is commonly caused by tooth extraction and dental trauma. Although genetic and pathological studies about MRONJ have been conducted, the pathogenesis of MRONJ still remains unclear. Methods: We aimed to identify genetic variants associated with MRONJ, using whole-exome sequencing (WES). Ten MRONJ patients prescribed bisphosphonates were recruited for WES, and jawbone tissue and blood samples were collected from the patients. Results: The analysis of the WES data found a total of 1866 SNP and 40 InDel variants which are specific to MRONJ. The functional classification assay using Gene Ontology and pathway analysis discovered that genes bearing the MRONJ variants are significantly enriched for keratinization and calcium ion transport. Some of the variants are potential pathogenic variants (24 missense mutations and seven frameshift mutations) with MAF < 0.01. Conclusions: The variants are located in eight different genes (KRT18, MUC5AC, NBPF9, PABPC3, MST1L, ASPN, ATN1, and SLAIN1). Nine deleterious SNPs significantly associated with MRONJ were found in the KRT18 and PABPC3 genes. It suggests that KRT18 and PABPC3 could be MRONJ-related key genes. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

Review

Jump to: Editorial, Research, Other

22 pages, 676 KiB  
Review
Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients—A Systematic Review
by Hemil Dario Rosales, Henry Garcia Guevara, Stefania Requejo, Maria Dianella Jensen, Julio Acero and Sergio Olate
J. Clin. Med. 2023, 12(4), 1416; https://doi.org/10.3390/jcm12041416 - 10 Feb 2023
Cited by 7 | Viewed by 2294
Abstract
Medication-related osteonecrosis of the jaw (MRONJ) is defined by the American Association of Oral and Maxillofacial Surgeons (AAOMS) as the presence of an exposed bone area in the maxillofacial region, present for more than eight weeks in patients treated with the use of [...] Read more.
Medication-related osteonecrosis of the jaw (MRONJ) is defined by the American Association of Oral and Maxillofacial Surgeons (AAOMS) as the presence of an exposed bone area in the maxillofacial region, present for more than eight weeks in patients treated with the use of antiresorptive or antiangiogenic agents, with no history of radiation or metastatic disease. Bisphosphonates (BF) and denosumab (DS) are widely used in adults for the management of patients with cancer and osteoporosis, and recently there has been an increase in their use in child and young patients for the management of disorders such as osteogenesis imperfecta (OI), glucocorticoid-induced osteoporosis, McCune-Albright syndrome (MAS), malignant hypercalcemia, and others. There are differences between case reports in adults compared to child and young patients related to the use of antiresorptive/antiangiogenic drugs and the development of MRONJ. The aim was to analyze the presence of MRONJ in children and young patients, and the relation with oral surgery. A systematic review, following the PRISMA search matrix based on the PICO question, was conducted in PubMed, Embase, ScienceDirect, Cochrane, Google Scholar, and manual search in high-impact journals between 1960 and 2022, publications in English or Spanish, including randomized and non-randomized clinical trials, prospective and retrospective cohort studies, cases and controls studies, and series and case reports. A total of 2792 articles were identified and 29 were included; all of them published between 2007 and 2022, identifying 1192 patients, 39.68% male and 36.24% female, aged 11.56 years old on average, using these drugs mainly for OI (60.15%); 4.21 years on average was the therapy time and 10.18 drug doses administered on average; oral surgery was observed in 216 subjects, reporting 14 cases of MRONJ. We concluded that there is a low presence of MRONJ in the child and youth population treated with antiresorptive drugs. Data collection is weak, and details of therapy are not clear in some cases. Deficiencies in protocols and pharmacological characterization were observed in most of the included articles. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

17 pages, 2226 KiB  
Review
Point-of-Care Virtual Surgical Planning and 3D Printing in Oral and Cranio-Maxillofacial Surgery: A Narrative Review
by Daniel Ostaș, Oana Almășan, Robert R. Ileșan, Vlad Andrei, Florian M. Thieringer, Mihaela Hedeșiu and Horațiu Rotar
J. Clin. Med. 2022, 11(22), 6625; https://doi.org/10.3390/jcm11226625 - 08 Nov 2022
Cited by 10 | Viewed by 2286
Abstract
This paper provides an overview on the use of virtual surgical planning (VSP) and point-of-care 3D printing (POC 3DP) in oral and cranio-maxillofacial (CMF) surgery based on a literature review. The authors searched PubMed, Web of Science, and Embase to find papers published [...] Read more.
This paper provides an overview on the use of virtual surgical planning (VSP) and point-of-care 3D printing (POC 3DP) in oral and cranio-maxillofacial (CMF) surgery based on a literature review. The authors searched PubMed, Web of Science, and Embase to find papers published between January 2015 and February 2022 in English, which describe human applications of POC 3DP in CMF surgery, resulting in 63 articles being included. The main review findings were as follows: most used clinical applications were anatomical models and cutting guides; production took place in-house or as “in-house—outsourced” workflows; the surgeon alone was involved in POC 3DP in 36 papers; the use of free versus paid planning software was balanced (50.72% vs. 49.27%); average planning time was 4.44 h; overall operating time decreased and outcomes were favorable, though evidence-based studies were limited; and finally, the heterogenous cost reports made a comprehensive financial analysis difficult. Overall, the development of in-house 3D printed devices supports CMF surgery, and encouraging results indicate that the technology has matured considerably. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

16 pages, 1855 KiB  
Review
Pitfalls and Challenges in Oral Plasma Cell Mucositis: A Systematic Review
by Noemi Coppola, Tiziana Cantile, Federica Canfora, Daniela Adamo, Paolo Bucci, Michele Davide Mignogna and Stefania Leuci
J. Clin. Med. 2022, 11(21), 6550; https://doi.org/10.3390/jcm11216550 - 04 Nov 2022
Cited by 3 | Viewed by 2118
Abstract
Plasma cell mucositis (PCM) is an unusual idiopathic disorder characterized by dense infiltrates of plasma cells in submucosa. Clinical phenotypes of oral plasma cell mucositis (o-PMC) are heterogenous. A systematic review has been conducted, aiming to synthesize the available evidence on o-PCM. Literature [...] Read more.
Plasma cell mucositis (PCM) is an unusual idiopathic disorder characterized by dense infiltrates of plasma cells in submucosa. Clinical phenotypes of oral plasma cell mucositis (o-PMC) are heterogenous. A systematic review has been conducted, aiming to synthesize the available evidence on o-PCM. Literature search, study design, and data analysis were performed following PRISMA guidelines. The SPIDER and the PICO tools were used to structure the research question. In all, 79 case reports and 19 case series on a total of 158 patients (85 females and 73 males; average age: 44.1 years) were identified. Among oral sites involved, gingiva (65.82%) was the most frequent site. The main clinical phenotype was erythema (99.37%). In relation to symptoms, pain (60.76%) was the most reported. On histological examination, all samples showed a dense inflammatory infiltration with predominant plasma cells. The treatment regimens of o-PCM were summarized in six groups: irritant removal; topical/systemic corticosteroids; topical/systemic immunosuppressants/immunomodulators; surgery and similar treatments; radiotherapy and chemotherapy; other therapies, such as antifungals, antibiotics, and antivirals drugs. This is the first systematic review aimed to synthesize the findings of studies on o-PCM. The lack of universally shared information on etiological factors and the absence of international consensus of pharmacological protocols make o-PCM a diagnostic and therapeutic challenge. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

22 pages, 526 KiB  
Review
The Bone Lid Technique in Oral and Maxillofacial Surgery: A Scoping Review
by Stefano Sivolella, Giulia Brunello, Sourav Panda, Lucia Schiavon, Fouad Khoury and Massimo Del Fabbro
J. Clin. Med. 2022, 11(13), 3667; https://doi.org/10.3390/jcm11133667 - 24 Jun 2022
Cited by 3 | Viewed by 2257
Abstract
This scoping review aimed at reporting the outcomes of the bone lid technique in oral surgery in terms of bone healing, ridge preservation, and incidence of complications. Bone-cutting instruments and stabilization methods were also considered. PubMed, Scopus, and the Cochrane Register of Controlled [...] Read more.
This scoping review aimed at reporting the outcomes of the bone lid technique in oral surgery in terms of bone healing, ridge preservation, and incidence of complications. Bone-cutting instruments and stabilization methods were also considered. PubMed, Scopus, and the Cochrane Register of Controlled Trials were searched using a combination of terms, including bone lid, bony window, piezosurgery, microsaw, cysts, endodontic surgery, impacted teeth, and maxillary sinus. A hand search was also performed. The last search was conducted on 30 November 2021. No date limitation was set. Searches were restricted to human clinical studies published in English. All types of study design were considered except reviews and case reports. After a two-step evaluation, 20 (2 randomized studies, 2 case-control studies, 3 cohort studies, 13 case series) out of 647 screened studies were included, reporting on 752 bone lid procedures. The bone lid technique was associated with favorable bone healing when compared to other methods, and with a very low incidence of major complications. Clinical indications, surgical procedures, study design, follow-up duration, and outcomes varied among the studies. Overall, favorable outcomes were reported using the bone lid approach, though evidence-based studies were scarce. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

Other

9 pages, 2516 KiB  
Case Report
Zygomatic Implant Insertion in MRONJ: A Case Report with a Follow-Up of 3 Years
by Funda Goker, Emma Grecchi, Massimo Del Fabbro, Salvatore Longoni, Luigi Vito Stefanelli and Francesco Grecchi
J. Clin. Med. 2023, 12(9), 3300; https://doi.org/10.3390/jcm12093300 - 05 May 2023
Cited by 2 | Viewed by 1125
Abstract
The oral rehabilitation of MRONJ patients represents a challenging situation. Conventional dental implant insertion is not indicated because of the risk of creating a new necrotic area. This case study describes the oral rehabilitation of a 78-year-old female patient, who developed an osteonecrotic [...] Read more.
The oral rehabilitation of MRONJ patients represents a challenging situation. Conventional dental implant insertion is not indicated because of the risk of creating a new necrotic area. This case study describes the oral rehabilitation of a 78-year-old female patient, who developed an osteonecrotic lesion in the fourth year of bisphosphonate treatment. The patient underwent a series of surgeries, including resection of the necrotic tissue on the right maxillary region and removal of conventional implants. The patient had a large maxillary defect, and no other treatment modalities such as conventional prosthetic appliances and traditional dental implant insertions were applicable. The patient had a very poor quality of life and as a rehabilitation option, two zygomatic implant insertions were planned and performed as an anchorage for maxillary fixed prosthesis. Radiographic and clinical examination after three years of follow-up indicated that healing was achieved, and healthy tissues formed around zygomatic implants. The patient did not suffer from any additional necrotic tissues or other complications in the oral cavity. According to the results of this case report, zygomatic implantation after resective surgery might be considered as a promising alternative for MRONJ patients with large defects when other treatment alternatives fail or are not applicable. Full article
(This article belongs to the Special Issue Breakthroughs in Oral and Maxillofacial Surgery)
Show Figures

Figure 1

Back to TopTop